Biosion

Nanjing, China · Founded 2017 · Privately Held (backing)

Developer of biomedical drugs intended for the treatment of immune and oncologic diseases. Biosion is based in Nanjing, China and was founded in 2017. Its last reported valuation was $182 million in Dec 2020. It has raised $133 million.

Last reported valuation

$182.3M

Oct 2026

Priced at

—

Total raised

$132.7M

Last round

—

How much has Biosion raised?

$132.7Macross 0 recorded rounds

Free account

More of Biosion with a free account

·The complete investor list: 17 names
·Watch Biosion: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Biosion investors

17 investors are on record for Biosion, including Addor Capital, Suzhou Guofa Venture Capital, Lapam Capital and GF Xinde Investment Management.

For fundraisers

Raising for a company like Biosion?

17 investors have backed Biosion.

See all 17 investors →

Frequently asked about Biosion

How much has Biosion raised?: Biosion has raised $132.7M in total across 0 recorded funding rounds.